Jefferies reiterates Summit Therapeutics stock rating after FDA setback

Verizon evp Kyle Malady sells $56,309 in company stock

Investing.com · News 18m ago

Social Security and the blue wave: What could happen to payroll taxes and senior tax breaks

CNBC · Economy 19m ago

M&T Bank Corp CEO Rene Jones sells $4.64 million in shares

Investing.com · News 33m ago

Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.

NASDAQ · Markets 34m ago

Microsoft Ignite Starts Nov. 17. Will Microsoft Update Its Paid Copilot Seat Count?

NASDAQ · Markets 46m ago

Consumers Bancorp SVP, chief people officer, buys $3,708 in shares

Investing.com · News 48m ago

Judge temporarily blocks Trump from moving ahead on Washington public golf course redevelopment

CNBC · Economy 51m ago

Is Credo Technology a Better AI Networking Buy Than Broadcom?

NASDAQ · Markets 52m ago

Cameco's CEO Says AI Isn't the Reason to Own Nuclear. Here's What He Says It Is.

NASDAQ · Markets 52m ago

Home Depot vs. Walmart: Which Consumer Stock Is a Better Buy for 2027?

NASDAQ · Markets 55m ago